-+ 0.00%
-+ 0.00%
-+ 0.00%

*Viking Therapeutics Phase 2 VENTURE-Oral Dosing Trial in Obesity Fully Enrolled; Data Expected 2H >VKTX

Dow Jones·04/23/2025 21:18:00

Please log in to view news